Ventas, Inc. - VTR STOCK NEWS

Land & Buildings Investment Management has voiced dissatisfaction with Ventas (NYSE: VTR), expressing concerns over its ongoing underperformance and undervaluation. In a letter to the Board, they announced intentions to vote against Lead Independent Director James Shelton and Chair Debra Cafaro at the upcoming Annual Meeting on May 16, 2023. Notably, Ventas has underperformed against peer Welltower (NYSE: WELL), with a 26% discount in cash flow multiple and a 130 basis points higher cap rate. Furthermore, Ventas is projecting a decline in Funds from Operations (FFO) in 2023 while Welltower anticipates growth. Land & Buildings emphasizes the need for significant changes in leadership and strategy to enhance shareholder value.

Integral Molecular, a key player in Philadelphia's biotech sector, has officially opened its new 32,000 square foot headquarters, which includes pandemic preparedness laboratories. This expansion at One uCity marks significant growth for the company, which will double its headquarter footprint and accommodate 200 employees, adding 100 new technology jobs. The facility will enhance Integral Molecular's capabilities in R&D and manufacturing, crucial for addressing future viral threats. The opening event featured local leaders, including Philadelphia Mayor Jim Kenney. The company has been instrumental in providing vital reagents during the COVID-19 pandemic and continues to contribute to advancing therapeutics against various viral diseases.

Ventas, Inc. (NYSE: VTR) will release its first quarter 2023 earnings after trading closes on May 8, 2023. A conference call to discuss these earnings is scheduled for May 9, 2023, at 10:00 a.m. ET. Investors can join the call by dialing (888) 330-3576 or +1 (646) 960-0672 internationally, using passcode 7655497. A live webcast will be available on www.ventasreit.com.

A telephonic replay will be accessible at (800) 770-2030 for 30 days post-call. Ventas operates a diversified portfolio of over 1,200 properties across the U.S., Canada, and the UK, focusing on healthcare and real estate driven by an aging population.

Ventas, Inc. (NYSE: VTR) announced the pricing terms for its cash tender offers via Ventas Canada Finance Limited, aiming to purchase outstanding notes previously detailed on April 3, 2023. The maximum purchase price increased from Cdn$500 million to Cdn$600 million. The Offers will expire at 5:00 p.m. Toronto time on May 1, 2023. Holders of validly tendered notes by the Early Tender Time will receive accrued interest until the expected Early Settlement Date of April 24, 2023. Due to high demand, all 2.80% Senior Notes, Series E will be accepted, while 4.125% Senior Notes, Series B will face a proration factor of approximately 45.2%.

Ventas, Inc. (NYSE: VTR) has announced early tender results for its cash tender offers, initially disclosed on April 3, 2023. The company has increased the Maximum Aggregate Purchase Price from Cdn$500 million to Cdn$600 million. As of the Early Tender Time, approximately Cdn$718.9 million of notes were validly tendered. Key points include:

• Approximately Cdn$718.9 million in notes validly tendered
• Acceptance of all Priority Level 1 notes, with Level 2 notes prorated
• Eligible tendered notes to receive a Cdn$30 Early Tender Payment
• Deadline for withdrawal was April 19, 2023, with the offers expiring on May 1, 2023

Further details can be found in the Offer to Purchase disclosure.

Ardent Health Services has announced the appointment of two new senior operations leaders and the promotion of three executives. Mike Matthews is the new president of Ardent Physician Services, focusing on medical group operations across eight markets. David Schultz takes on the role of president for Ardent's New Mexico market, overseeing five hospitals and over 30 care sites. Additionally, Lisa Dolan has been promoted to senior vice president and chief nursing officer, enhancing quality and safety for over 7,000 nurses. Reed Smith will now serve as chief consumer officer, while Rebecca Kirkham has been named chief communications officer. The leadership changes aim to bolster patient engagement and advance value-based care networks.

Ventas, Inc. announced the pricing of a private offering in Canada, totaling Cdn$600 million of 5.398% Senior Notes, Series I due 2028. The offering is set to close on April 21, 2023. The Notes will be issued by the Company's wholly-owned subsidiary, Ventas Canada Finance Limited, and are unconditionally guaranteed by Ventas. Proceeds will fund tender offers to purchase existing Senior Notes due in 2024, totaling up to Cdn$500 million, with any remaining funds allocated for working capital. The Notes will mature on April 21, 2028, with interest payable semi-annually.